NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/06/2026
Voltar para busca
Dado oficial do USPTO
BUMBLE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
84
Atualização mais recente
30/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
20/12/2019
Data de registro
30/06/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/06/2026
Última transação
30/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
London, GB
Examinador
PINO, DOMINIC ROBERT
Unidade examinadora
N90
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of a hexagon with rounded corners that includes three lines with rounded corners, which forms the appearance of a beehive, placed to the left of the word "BUMBLE".
Titulares e representantes
Titulares
Bumble Holding Limited
Representantes
Winfield B. Martin Perkins Coie LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalsantibacterial pharmaceuticalsocular pharmaceuticalspharmaceuticals for the treatment of viral infectionspharmaceuticals for the treatment of viral diseasestherapeutic pharmaceuticals for the treatment of sexually transmitted infectionspharmaceuticals for the treatment of hormonal disordersinjectable contraceptivesinducers of erectionseffervescent analgesic pharmaceutical preparationsbismuth preparations for pharmaceutical purposesanti-infectivesroyal jelly for pharmaceutical purposespharmaceutical preparations for treating sunburnpharmaceutical preparations for skin carebalms for pharmaceutical purposespharmaceutical skin lotionsanti-diabetic pharmaceuticalspharmaceutical products for the prevention and treatment of cancerpharmaceutical preparations for treating chemical imbalancespharmaceutical agents affecting sensory organspharmaceutical agents affecting metabolismanalgesic and muscle relaxant pharmaceutical preparationspharmaceutical preparations for treating dandruff; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system related diseases and disorders; medical preparationsdiagnostic preparations for medical purposes; medical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system related diseases and disorders; veterinary preparationsantioxidants and diagnostic preparations for veterinary purposes; veterinary preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system related diseases and disorders; sanitary preparations for medical purposes; dietetic foods adapted for medical or veterinary use; medical plasters; material for dressingswading for dressings; medicated lotions and creamsanti-fly lotionmedicated hair lotionscalamine lotionsmedicated after-shave lotionssports cream for relief of painmedical creams for skin careorgasm creamstopical analgesic creamsanti-itch creamsantibiotic creamscreams for dermatological usemedicated cream soap; antiseptic creamsmedicated diaper nappy-rash creamsmedicated preparations for the care of sunburn; material for stopping teethdental wax; disinfectants; fungicidesherbicides; personal sexual lubricants; sexual stimulant gels; sanitary preparations for medical use; hand sanitizers; none of the aforesaid being products which contain ingredients derived from bees
Publicações
Histórico de despachos e eventos da marca no USPTO.
84 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
30/06/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2026
PUBO
PUBLISHED FOR OPPOSITION
12/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/05/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/04/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/04/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
01/04/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/01/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/01/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/01/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/01/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/01/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/01/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/04/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
25/04/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
30/01/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
30/01/2025
CNSI
SUSPENSION INQUIRY WRITTEN
30/01/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
29/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/07/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25/07/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
25/07/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/05/2024
GNSL
LETTER OF SUSPENSION E-MAILED
13/05/2024
CNSL
SUSPENSION LETTER WRITTEN
13/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/05/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
27/02/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
27/02/2024
CNSI
SUSPENSION INQUIRY WRITTEN
27/02/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
23/02/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
22/08/2023
GNSL
LETTER OF SUSPENSION E-MAILED
22/08/2023
CNSL
SUSPENSION LETTER WRITTEN
22/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/08/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
21/08/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/06/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/06/2023
CNSI
SUSPENSION INQUIRY WRITTEN
06/06/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
22/05/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/11/2022
GNSL
LETTER OF SUSPENSION E-MAILED
15/11/2022
CNSL
SUSPENSION LETTER WRITTEN
15/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/11/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/11/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
15/06/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
15/06/2022
CNSI
SUSPENSION INQUIRY WRITTEN
15/06/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/12/2021
GNSL
LETTER OF SUSPENSION E-MAILED
08/12/2021
CNSL
SUSPENSION LETTER WRITTEN
08/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2021
ALIE
ASSIGNED TO LIE
07/12/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/12/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
16/06/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
16/06/2021
CNSI
SUSPENSION INQUIRY WRITTEN
16/06/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
28/09/2020
GNSL
LETTER OF SUSPENSION E-MAILED
28/09/2020
CNSL
SUSPENSION LETTER WRITTEN
28/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/04/2020
GNRT
NON-FINAL ACTION E-MAILED
07/04/2020
CNRT
NON-FINAL ACTION WRITTEN
07/04/2020
DOCK
ASSIGNED TO EXAMINER
18/03/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
31/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/12/2019
NWAP
NEW APPLICATION ENTERED
24/12/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BUMBLE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.